Orbimed Advisors - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$46,978,295
-11.6%
2,029,3000.0%0.92%
-9.3%
Q4 2022$53,167,660
+33.3%
2,029,3000.0%1.02%
+37.2%
Q3 2022$39,896,000
+20.3%
2,029,300
+7.0%
0.74%
+23.3%
Q2 2022$33,166,000
+42.9%
1,896,300
+33.7%
0.60%
+59.8%
Q1 2022$23,203,000
+0.3%
1,418,3000.0%0.38%
+26.6%
Q4 2021$23,132,000
+27.6%
1,418,300
-0.2%
0.30%
+49.2%
Q3 2021$18,127,000
-3.7%
1,420,637
+6.5%
0.20%
+4.7%
Q2 2021$18,833,000
-3.0%
1,333,801
+6.7%
0.19%
+4.4%
Q1 2021$19,425,000
-2.0%
1,250,0010.0%0.18%
+5.2%
Q4 2020$19,825,0001,250,0010.17%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 3,168,388$50,251,0005.05%
ATP Life Science Ventures, L.P. 4,028,937$63,859,0004.93%
Affinity Asset Advisors, LLC 150,000$2,379,0001.26%
Altium Capital Management LP 205,799$3,264,0001.22%
EcoR1 Capital, LLC 1,250,001$19,825,0001.07%
Vivo Capital, LLC 1,206,266$19,131,0000.85%
Marquette Asset Management, LLC 182,036$2,887,0000.66%
Monashee Investment Management LLC 272,949$4,329,0000.57%
Ally Bridge Group (NY) LLC 199,600$3,166,0000.54%
Rubric Capital Management LP 325,863$5,168,0000.38%
View complete list of CHINOOK THERAPEUTICS INC shareholders